Catalyst Wire Dossier Catalyst Wire Dossier

Alrex

loteprednol etabonate · Bausch & Lomb Incorporated
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Alrex, covering 2012-03-13 to 2019-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis [Phase 4]

See pricing